Copyright Reports & Markets. All rights reserved.

Global Peptide Therapeutics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Peptide Therapeutics Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type
    • 1.2.2 Injection
    • 1.2.3 Oral
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Peptide Therapeutics Market Size Growth Rate by Application
    • 1.3.2 Cancer
    • 1.3.3 Metabolic Disorders
    • 1.3.4 Central Nervous System
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Peptide Therapeutics Market Size Estimates and Forecasts
    • 2.1.1 Global Peptide Therapeutics Revenue 2015-2026
    • 2.1.2 Global Peptide Therapeutics Sales 2015-2026
  • 2.2 Peptide Therapeutics Market Size by Region: 2020 Versus 2026
  • 2.3 Peptide Therapeutics Sales by Region (2015-2026)
    • 2.3.1 Global Peptide Therapeutics Sales by Region: 2015-2020
    • 2.3.2 Global Peptide Therapeutics Sales Forecast by Region (2021-2026)
    • 2.3.3 Global Peptide Therapeutics Sales Market Share by Region (2015-2026)
  • 2.4 Peptide Therapeutics Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Peptide Therapeutics Revenue by Region: 2015-2020
    • 2.4.2 Global Peptide Therapeutics Revenue Forecast by Region (2021-2026)
    • 2.4.3 Global Peptide Therapeutics Revenue Market Share by Region (2015-2026)

3 Global Peptide Therapeutics by Manufacturers

  • 3.1 Global Top Peptide Therapeutics Manufacturers by Sales
    • 3.1.1 Global Peptide Therapeutics Sales by Manufacturer (2015-2020)
    • 3.1.2 Global Peptide Therapeutics Sales Market Share by Manufacturer (2015-2019)
  • 3.2 Global Top Peptide Therapeutics Manufacturers by Revenue
    • 3.2.1 Global Peptide Therapeutics Revenue by Manufacturer (2015-2020)
    • 3.2.2 Global Peptide Therapeutics Revenue Share by Manufacturer (2015-2020)
  • 3.3 Global Peptide Therapeutics Price by Manufacturer (2015-2020)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Peptide Therapeutics Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI) & (2015-2020)
    • 3.4.3 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.5 Global Peptide Therapeutics Manufacturing Base Distribution, Product Type
    • 3.5.1 Peptide Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Peptide Therapeutics Product Type
    • 3.5.3 Date of International Manufacturers Enter into Peptide Therapeutics Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

  • 4.1 Sanofi
    • 4.1.1 Sanofi Corporation Information
    • 4.1.2 Sanofi Description, Business Overview
    • 4.1.3 Sanofi Peptide Therapeutics Products Offered
    • 4.1.4 Sanofi Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.1.5 Sanofi Peptide Therapeutics Revenue by Product
    • 4.1.6 Sanofi Peptide Therapeutics Revenue by Application
    • 4.1.7 Sanofi Peptide Therapeutics Revenue by Geographic Area
    • 4.1.8 Sanofi Peptide Therapeutics Revenue by Sales Channel
    • 4.1.9 Sanofi Recent Development
  • 4.2 Eli Lilly
    • 4.2.1 Eli Lilly Corporation Information
    • 4.2.2 Eli Lilly Description, Business Overview
    • 4.2.3 Eli Lilly Peptide Therapeutics Products Offered
    • 4.2.4 Eli Lilly Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.2.5 Eli Lilly Peptide Therapeutics Revenue by Product
    • 4.2.6 Eli Lilly Peptide Therapeutics Revenue by Application
    • 4.2.7 Eli Lilly Peptide Therapeutics Revenue by Geographic Area
    • 4.2.8 Eli Lilly Peptide Therapeutics Revenue by Sales Channel
    • 4.2.9 Eli Lilly Recent Development
  • 4.3 Novo Nordisk
    • 4.3.1 Novo Nordisk Corporation Information
    • 4.3.2 Novo Nordisk Description, Business Overview
    • 4.3.3 Novo Nordisk Peptide Therapeutics Products Offered
    • 4.3.4 Novo Nordisk Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.3.5 Novo Nordisk Peptide Therapeutics Revenue by Product
    • 4.3.6 Novo Nordisk Peptide Therapeutics Revenue by Application
    • 4.3.7 Novo Nordisk Peptide Therapeutics Revenue by Geographic Area
    • 4.3.8 Novo Nordisk Peptide Therapeutics Revenue by Sales Channel
    • 4.3.9 Novo Nordisk Recent Development
  • 4.4 Takeda
    • 4.4.1 Takeda Corporation Information
    • 4.4.2 Takeda Description, Business Overview
    • 4.4.3 Takeda Peptide Therapeutics Products Offered
    • 4.4.4 Takeda Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.4.5 Takeda Peptide Therapeutics Revenue by Product
    • 4.4.6 Takeda Peptide Therapeutics Revenue by Application
    • 4.4.7 Takeda Peptide Therapeutics Revenue by Geographic Area
    • 4.4.8 Takeda Peptide Therapeutics Revenue by Sales Channel
    • 4.4.9 Takeda Recent Development
  • 4.5 Teva
    • 4.5.1 Teva Corporation Information
    • 4.5.2 Teva Description, Business Overview
    • 4.5.3 Teva Peptide Therapeutics Products Offered
    • 4.5.4 Teva Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.5.5 Teva Peptide Therapeutics Revenue by Product
    • 4.5.6 Teva Peptide Therapeutics Revenue by Application
    • 4.5.7 Teva Peptide Therapeutics Revenue by Geographic Area
    • 4.5.8 Teva Peptide Therapeutics Revenue by Sales Channel
    • 4.5.9 Teva Recent Development
  • 4.6 Novartis
    • 4.6.1 Novartis Corporation Information
    • 4.6.2 Novartis Description, Business Overview
    • 4.6.3 Novartis Peptide Therapeutics Products Offered
    • 4.6.4 Novartis Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.6.5 Novartis Peptide Therapeutics Revenue by Product
    • 4.6.6 Novartis Peptide Therapeutics Revenue by Application
    • 4.6.7 Novartis Peptide Therapeutics Revenue by Geographic Area
    • 4.6.8 Novartis Recent Development
  • 4.7 AstraZeneca
    • 4.7.1 AstraZeneca Corporation Information
    • 4.7.2 AstraZeneca Description, Business Overview
    • 4.7.3 AstraZeneca Peptide Therapeutics Products Offered
    • 4.7.4 AstraZeneca Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.7.5 AstraZeneca Peptide Therapeutics Revenue by Product
    • 4.7.6 AstraZeneca Peptide Therapeutics Revenue by Application
    • 4.7.7 AstraZeneca Peptide Therapeutics Revenue by Geographic Area
    • 4.7.8 AstraZeneca Recent Development
  • 4.8 Ipsen
    • 4.8.1 Ipsen Corporation Information
    • 4.8.2 Ipsen Description, Business Overview
    • 4.8.3 Ipsen Peptide Therapeutics Products Offered
    • 4.8.4 Ipsen Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.8.5 Ipsen Peptide Therapeutics Revenue by Product
    • 4.8.6 Ipsen Peptide Therapeutics Revenue by Application
    • 4.8.7 Ipsen Peptide Therapeutics Revenue by Geographic Area
    • 4.8.8 Ipsen Recent Development
  • 4.9 AbbVie
    • 4.9.1 AbbVie Corporation Information
    • 4.9.2 AbbVie Description, Business Overview
    • 4.9.3 AbbVie Peptide Therapeutics Products Offered
    • 4.9.4 AbbVie Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.9.5 AbbVie Peptide Therapeutics Revenue by Product
    • 4.9.6 AbbVie Peptide Therapeutics Revenue by Application
    • 4.9.7 AbbVie Peptide Therapeutics Revenue by Geographic Area
    • 4.9.8 AbbVie Recent Development
  • 4.10 Allergan
    • 4.10.1 Allergan Corporation Information
    • 4.10.2 Allergan Description, Business Overview
    • 4.10.3 Allergan Peptide Therapeutics Products Offered
    • 4.10.4 Allergan Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.10.5 Allergan Peptide Therapeutics Revenue by Product
    • 4.10.6 Allergan Peptide Therapeutics Revenue by Application
    • 4.10.7 Allergan Peptide Therapeutics Revenue by Geographic Area
    • 4.10.8 Allergan Recent Development
  • 4.11 Ferring
    • 4.11.1 Ferring Corporation Information
    • 4.11.2 Ferring Description, Business Overview
    • 4.11.3 Ferring Peptide Therapeutics Products Offered
    • 4.11.4 Ferring Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.11.5 Ferring Peptide Therapeutics Revenue by Product
    • 4.11.6 Ferring Peptide Therapeutics Revenue by Application
    • 4.11.7 Ferring Peptide Therapeutics Revenue by Geographic Area
    • 4.11.8 Ferring Recent Development
  • 4.12 Merck
    • 4.12.1 Merck Corporation Information
    • 4.12.2 Merck Description, Business Overview
    • 4.12.3 Merck Peptide Therapeutics Products Offered
    • 4.12.4 Merck Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.12.5 Merck Peptide Therapeutics Revenue by Product
    • 4.12.6 Merck Peptide Therapeutics Revenue by Application
    • 4.12.7 Merck Peptide Therapeutics Revenue by Geographic Area
    • 4.12.8 Merck Recent Development
  • 4.13 J & J
    • 4.13.1 J & J Corporation Information
    • 4.13.2 J & J Description, Business Overview
    • 4.13.3 J & J Peptide Therapeutics Products Offered
    • 4.13.4 J & J Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.13.5 J & J Peptide Therapeutics Revenue by Product
    • 4.13.6 J & J Peptide Therapeutics Revenue by Application
    • 4.13.7 J & J Peptide Therapeutics Revenue by Geographic Area
    • 4.13.8 J & J Recent Development
  • 4.14 The Medicines
    • 4.14.1 The Medicines Corporation Information
    • 4.14.2 The Medicines Description, Business Overview
    • 4.14.3 The Medicines Peptide Therapeutics Products Offered
    • 4.14.4 The Medicines Peptide Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 4.14.5 The Medicines Peptide Therapeutics Revenue by Product
    • 4.14.6 The Medicines Peptide Therapeutics Revenue by Application
    • 4.14.7 The Medicines Peptide Therapeutics Revenue by Geographic Area
    • 4.14.8 The Medicines Recent Development

5 Breakdown Data by Type

  • 5.1 Global Peptide Therapeutics Sales by Type (2015-2026)
    • 5.1.1 Global Peptide Therapeutics Sales by Type (2015-2020)
    • 5.1.2 Global Peptide Therapeutics Sales Forecast by Type (2021-2026)
    • 5.1.3 Global Peptide Therapeutics Sales Market Share by Type (2015-2026)
  • 5.2 Global Peptide Therapeutics Revenue Forecast by Type (2015-2026)
    • 5.2.1 Global Peptide Therapeutics Revenue by Type (2015-2020)
    • 5.2.2 Global Peptide Therapeutics Revenue Forecast by Type (2021-2026)
    • 5.2.3 Global Peptide Therapeutics Revenue Market Share by Type (2015-2026)
  • 5.3 Peptide Therapeutics Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

  • 6.1 Global Peptide Therapeutics Sales by Application (2015-2026)
    • 6.1.1 Global Peptide Therapeutics Sales by Application (2015-2020)
    • 6.1.2 Global Peptide Therapeutics Sales Forecast by Application (2021-2026)
    • 6.1.3 Global Peptide Therapeutics Sales Market Share by Application (2015-2026)
  • 6.2 Global Peptide Therapeutics Revenue Forecast by Application (2015-2026)
    • 6.2.1 Global Peptide Therapeutics Revenue by Application (2015-2020)
    • 6.2.2 Global Peptide Therapeutics Revenue Forecast by Application (2021-2026)
    • 6.2.3 Global Peptide Therapeutics Revenue Market Share by Application (2015-2026)
  • 6.3 Peptide Therapeutics Average Selling Price (ASP) by Application (2015-2026)

7 North America

  • 7.1 North America Peptide Therapeutics Market Size YoY Growth 2015-2026
  • 7.2 North America Peptide Therapeutics Market Facts & Figures by Country
    • 7.2.1 North America Peptide Therapeutics Sales by Country (2015-2026)
    • 7.2.2 North America Peptide Therapeutics Revenue by Country (2015-2026)
  • 7.3 North America Peptide Therapeutics Sales by Type
  • 7.4 North America Peptide Therapeutics Sales by Application

8 Asia-Pacific

  • 8.1 Asia-Pacific Peptide Therapeutics Market Size YoY Growth 2015-2026
  • 8.2 Asia-Pacific Peptide Therapeutics Market Facts & Figures by Region
    • 8.2.1 Asia-Pacific Peptide Therapeutics Sales by Region (2015-2026)
    • 8.2.2 Asia-Pacific Peptide Therapeutics Revenue by Region (2015-2026)
  • 8.3 Asia-Pacific Peptide Therapeutics Sales by Type
  • 8.4 Asia-Pacific Peptide Therapeutics Sales by Application

9 Europe

  • 9.1 Europe Peptide Therapeutics Market Size YoY Growth 2015-2026
  • 9.2 Europe Peptide Therapeutics Market Facts & Figures by Country
    • 9.2.1 Europe Peptide Therapeutics Sales by Country (2015-2026)
    • 9.2.2 Europe Peptide Therapeutics Revenue by Country (2015-2026)
  • 9.3 Europe Peptide Therapeutics Sales by Type
  • 9.4 Europe Peptide Therapeutics Sales by Application

10 Latin America

  • 10.1 Latin America Peptide Therapeutics Market Size YoY Growth 2015-2026
  • 10.2 Latin America Peptide Therapeutics Market Facts & Figures by Country
    • 10.2.1 Latin America Peptide Therapeutics Sales by Country (2015-2026)
    • 10.2.2 Latin America Peptide Therapeutics Revenue by Country (2015-2026)
  • 10.3 Latin America Peptide Therapeutics Sales by Type
  • 10.4 Latin America Peptide Therapeutics Sales by Application

11 Middle East and Africa

  • 11.1 Middle East and Africa Peptide Therapeutics Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Peptide Therapeutics Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Peptide Therapeutics Sales by Country (2015-2026)
    • 11.2.2 Middle East and Africa Peptide Therapeutics Revenue by Country (2015-2026)
  • 11.3 Middle East and Africa Peptide Therapeutics Sales by Type
  • 11.4 Middle East and Africa Peptide Therapeutics Sales by Application

12 Supply Chain and Sales Channel Analysis

  • 12.1 Peptide Therapeutics Supply Chain Analysis
  • 12.2 Peptide Therapeutics Key Raw Materials and Upstream Suppliers
  • 12.3 Peptide Therapeutics Clients Analysis
  • 12.4 Peptide Therapeutics Sales Channel and Sales Model Analysis
    • 12.4.1 Peptide Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 12.4.2 Peptide Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
    • 12.4.3 Peptide Therapeutics Distributors

13 Market Dynamics

  • 13.1 Peptide Therapeutics Market Drivers
  • 13.2 Peptide Therapeutics Market Opportunities
  • 13.3 Peptide Therapeutics Market Challenges
  • 13.4 Peptide Therapeutics Market Restraints
  • 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Peptide Therapeutics market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Peptide Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

    Segment by Type, the Peptide Therapeutics market is segmented into
    Injection
    Oral
    Other
    The proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.

    Segment by Application, the Peptide Therapeutics market is segmented into
    Cancer
    Metabolic Disorders
    Central Nervous System
    Other
    The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.

    Regional and Country-level Analysis:
    North America
    United States
    Canada
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Southeast Asia
    Australia
    Rest of Asia-Pacific
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic Countries
    Rest of Europe
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    Competitive Landscape and Peptide Therapeutics Market Share Analysis
    Peptide Therapeutics market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Peptide Therapeutics product introduction, recent developments, Peptide Therapeutics sales by region, type, application and by sales channel.

    The major companies include:
    Sanofi
    Eli Lilly
    Novo Nordisk
    Takeda
    Teva
    Novartis
    AstraZeneca
    Ipsen
    AbbVie
    Allergan
    Ferring
    Merck
    J & J
    The Medicines

    Buy now